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Abstract
Background: Methodological development of joint models of longitudinal and survival data has been rapid in
recent years; however, their full potential in applied settings are yet to be fully explored. We describe a novel use of a
specific association structure, linking the two component models through the subject specific intercept, and thus
extend joint models to account for measurement error in a biomarker, even when only the baseline value of the
biomarker is of interest. This is a common occurrence in registry data sources, where often repeated measurements
exist but are simply ignored.
Methods: The proposed specification is evaluated through simulation and applied to data from the General Practice
Research Database, investigating the association between baseline Systolic Blood Pressure (SBP) and the
time-to-stroke in a cohort of obese patients with type 2 diabetes mellitus.
Results: By directly modelling the longitudinal component we reduce bias in the hazard ratio for the effect of
baseline SBP on the time-to-stroke, showing the large potential to improve on previous prognostic models which use
only observed baseline biomarker values.
Conclusions: The joint modelling of longitudinal and survival data is a valid approach to account for measurement
error in the analysis of a repeatedly measured biomarker and a time-to-event. User friendly Stata software is provided.
Background
Many biomarkers such as systolic blood pressure (SBP)
have been identified as key prognostic factors in the devel-
opment and validation of cardiovascular risk scores [1,2].
However, often only baseline values of these biomark-
ers are used, despite the existence of repeated measures,
especially in registry sources such as the General Practice
Research Database (GPRD) [3]. Furthermore, biomark-
ers are often measured with error. Failing to adjust for
such measurement error leads to estimates being biased
towards the null [4].
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A joint model of longitudinal and survival data allows
us to investigate the relationship between a repeatedly
measured biomarker, subject to measurement error, such
as SBP, and the time to an event of interest, such as
time to non-fatal stroke. The approach which has dom-
inated the methodological literature involves linking the
two component submodels using shared random effects
[5,6]. From a classical perspective, these methods require
computationally intensive numerical integration, which is
difficult to implement. However, due to the recent intro-
duction of user-friendly software in R [7,8] and Stata [9],
these models are starting to find their place in applied
research [10,11], but the potential uses of and forms of
the association parameters, linking the longitudinal and
survival components, are yet to be fully explored. Alterna-
tively, many authors have proposed a Bayesian approach,
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proving readily available BUGS code to implement the
models [12,13].
The most commonly used association structures
include the current value parameterisation [5]; whereby
we directly link the value of the biomarker, as estimated
by the longitudinal submodel, to survival, and the first
derivative or slope [10]; allowing the investigation of the
effect that the rate of change of the biomarker has on
survival.
There is often interest in predicting prognosis based
on an initial baseline measurement [1,2]. In this paper
we investigate the use of the joint model framework with
a random intercept association structure as an approach
to adjust for measurement error, inherent in biomarkers
such as SBP. By incorporating the repeated measures we
thus make the most efficient use of the data available.
In particular, as a prognostic model for future patients,
we describe how this framework can be used to pre-
dict survival for new patients who will only have baseline
measurements.
Methods
A joint model of longitudinal and survival data consists
of two component submodels: the longitudinal submodel
and the survival submodel. We define a set of baseline
covariates, U i, which can potentially differ between sub-
models. The longitudinal submodel allows us tomodel the
trajectory of a repeatedly measured biomarker over time,
adjusting for baseline covariates. The standard approach
assumes a linear mixed effects model [14]. We observe
Yi(tij) = Wi(tij) + ij, ij ∼ N(0, σ 2e ) (1)
with
Wi(tij) = X′i(tij)β + Z′i(tij)bi + uiδ (2)
where Yi(tij) is the observed longitudinal response for
the ith patient measured at the jth time point. Wi(tij)
is our true unobserved trajectory function consisting of
designmatricesX′i(tij) andZ′i(tij) for the fixed and random
effects, β and bi, respectively, where bi ∼ MVN(0,).
We can incorporate flexibility here by allowing bothX′i(tij)
and Z′i(tij) to contain restricted cubic spline functions of
measurement time [15]. We also have a vector of baseline
covariates ui ∈ U i, and corresponding regression coeffi-
cients, δ. Finally, ij is our normally distributed measure-
ment error with constant variance σ 2e . We further assume
that the random effects and error term are independent,
and that cov(ij, ik) = 0 (where j = k).
The time-to-event submodel usually takes the form of a
proportional hazards model
hi(t) = h0(t) exp(α1Wi(t) + φvi) (3)
with h0(t) the baseline hazard function and vi ∈ U i is
a vector of baseline covariates with corresponding log
hazard ratios, φ. The parameter α1 is commonly named
the association parameter, indicating the strength of asso-
ciation between the longitudinal biomarker and the time
to event. If α1 = 0, then the joint model reduces to
the two separate models and fitting a joint model will
not prove advantageous. This parameterisation assumes
the hazard is dependent on the biomarker through its
current value. This form of association is one of many
ways to link the two component sub-models. The baseline
hazard function, h0(t), can be modelled using a para-
metric distribution, most frequently the Weibull, or less
restrictively using flexible parametric survival models
[16], or of course can be left unspecified [17]. However,
an unspecified baseline hazard function leads to under-
estimation of the standard errors of parameter estimates
[18], and consequently bootstrapping is required to obtain
appropriate standard errors.
For illustration, we let Wi(tij), the longitudinal sub-
model, be a linear function of timewhere the intercept and
slope varies between subjects
Wi(tij) = (β0 + b0i) + (β1 + b1i)tij (4)
giving a model with a random intercept and random lin-
ear slope. As an alternative way of linking the component
models to that of Equation (3), we may link elements
of the trajectory function, Wi(tij), to the hazard directly.
For example, we can link the subject specific baseline
biomarker values through the intercept association struc-
ture, where
hi(t) = h0(t) exp [α2(β0 + b0i) + φvi] (5)
in this expression α2 now estimates the strength of
the association between the patient specific baseline
biomarker values, as estimated by the longitudinal sub-
model, and the time-to-event. This way we can let the risk
of event depend directly on the subject specific value of
the biomarker at time t = 0.
If interest lies in prediction when a new patient is
observed at baseline, the issue of measurement error can
be accounted for through this approach. A benefit of this
association structure also lies in the evaluation of the joint
likelihood. Under most parametric survival submodels
(e.g. Weibull distribution) and time-dependent associa-
tion structures (eg. current value), numerical quadrature
is required to integrate out not only the random effects,
but under Equation (3), nested quadrature is also required
to evaluate the cumulative hazard function. Under the
time-independent association structure of Equation (5),
we avoid this nested quadrature as the cumulative
hazard function has an analytically tractable form, which
provides computational benefits.
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As discussed in the introduction, this model formula-
tion can be an alternative to the standard approach of
using the observed baseline biomarker value
hi(t) = h0i(t) exp(α3Y0i + φvi) (6)
where Y0i is the observed baseline biomarker value and
α3 is the log hazard ratio for a one unit increase in the
observed baseline biomarker value. Although simple to fit,
Equation (6) does not account for potential measurement
error in Y0i.
Simulation study
In order to assess the performance of the standard
approach of including observed biomarker values, com-
pared to the full joint model described above, we evalu-
ated both through simulation [19]. For ease of exposition
we assume a longitudinal model with random intercept
and slope, assuming a continuous biomarker of interest
with
Wi(tij) = (β0 + b0i) + (β1 + b1i)tij
where β0 = β1 = 0, and b0i ∼ N(0, 1), b1i ∼ N(0, 0.252)
with correlation between (b0i, b1i) of 0.25. Observed mea-
surements are then generated from Yij ∼ N(Wi(tij), σ 2e ),
where tij is the time of the jth measurement for the ith
patient. We vary σe from {0.1, 0.5, 1}.
We assume a Weibull baseline hazard function with
λ = 0.1 and γ = 1.5. A binary variable, X1 to rep-
resent treatment group was generated from Bin(1, 0.5),
with an associated log hazard ratio of φ1 = −0.5. A con-
tinuous covariate, X2, to represent age at baseline was
generated from N(65, 12) with an associated log hazard
ratio of φ2 = 0.01. We then generate survival times
from a Weibull distribution where the hazard is defined
as h(t) = h0(t) exp(α2β0i + φ1X1 + φ2X2), with α2 the
association parameter, indicating the effect of a one unit
increase in the value of the subject specific intercept on
the risk of event.We vary α2 = {−0.5, 0.25, 0.25, 0.5}. Each
simulation contained 300 patients with up to 5 annual
measurements (including baseline), and administrative
censoring at 5 years. This corresponds to an approximate
18.9% survival proportion at 5 years (calculated at the
mean of covariate values, X1 = 12 ,X2 = 65 and β0i = 0).
To each dataset we fit a Weibull proportional hazards
model including the observed baseline measurement, and
a Weibull-based joint model with the random intercept
association structure. We adjust for age and treatment in
the survival submodel. Each scenario is simulated 1000
times.
To illustrate the varying measurement error standard
deviations used in the simulation scenarios, we show in
Figure 1 observed longitudinal measurements from the
same 100 patients with σe = {0.1, 0.5, 1}, and when
α = 0.25. Figure 1 illustrates that as the measurement
error standard deviation increases, the variability in the
observed biomarker values increases.
The GPRD cohort
The General Practice Research Database (GPRD) Group
has obtained ethical approval from a Multi-centre
Research Ethics Committee (MREC) for all purely obser-
vational research using GPRD data; namely, studies which
do not include patient involvement The core work of
the GPRD is covered by MREC approval granted by the
Trent Multi- Research Ethics Committee (REC reference
number 05/MRE04/87) and this study was approved by
the GPRD Independent Scientific Advisory Committee
(ISAC) (Protocol number 09_094). This study is based in
part on data from GPRD obtained under licence from
the UK Medicines and Healthcare Product Regulatory
Agency (MHRA). However, the interpretation and con-
clusions contained in this study are those of the authors
alone.
The example cohort used to illustrate the methods in
this paper consists of 4,850 obese patients diagnosed with
type 2 diabetes mellitus. We have 107,347 measurements
of SBP, with maximum follow-up of 22 years. There were
278 stroke events observed.
In Figure 2 we show the observed SBP measure-
ments for 9 randomly selected patients, who had at least
10 measurements, illustrating some nonlinear trajecto-
ries. To accommodate such nonlinearities we can use
restricted cubic splines in the linear mixed effects sub-
model. In particular, we specify the following longitudinal
submodel
Wi(tij) = (β0 + b0i) + β1agei + β2sexi + β3BMIi
+ (βFsF(tij; kF) + bRsR(tij; kR))
(7)
Where sF(tij; kF) is the restricted cubic spline basis of
measurement time with corresponding fixed effects, βF ,
with knot locations kF , and sR(tij; kR) is the restricted
cubic spline basis of measurement time with correspond-
ing random effects, bR, and knot locations kR.
Prelimenary modelling of the longitudinal data can be
conducted to guide model selection, in particular, the
degrees of freedom for the spline terms capturing the
underlying longitudinal trajectory over time.
To allow flexibility in the survival submodel we use the
flexible parametric survival model [16,20], which mod-
els the baseline log cumulative hazard function using
resticted cubic splines. We can once again undertake
seperate analysis of just the survival data to inform model
selection. In particular, we can use the AIC and BIC to
guide the selection of the number of degrees of free-
dom to capture the baseline hazard function, following
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Figure 2 Longitudinal response measurements for SBP for 9 randomly selected patients who had at least 10 measurements. The dashed
line represents the fitted longitudinal trajectories based on the joint model.
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Rutherford et al. (2013) [21]. Our final joint model is
then
log [Hi(t)] = log [H0(t)] + φ1 agei + φ2 sexi + φ3 BMIi
+ α2(β0 + b0i)
(8)
where
log [H0(t)] = s(log(t); γ , kS) (9)
where the baseline log cumulative hazard function,
log [H0(t)], is expanded into a restricted cubic spline func-
tion of log(t), s(log(t); γ , kS), with knot locations kS and
coefficient vector, γ . This framework has recently been
incorporated into a joint model [22]. In each submodel
we adjust for the baseline effects of age, sex and BMI.
We fit the joint model with the random intercept asso-
ciation structure shown in Equation (5). For comparison,
we also apply the standard flexible parametric survival




Bias and coverage estimates for the association parame-
ter are presented in Table 1. Under the standard Weibull
model, we observe increasing bias in the estimates of
the association between baseline biomarker values and
survival, as the magnitude of the measurement error stan-
dard deviation, σe, increases. In parallel we observe very
poor coverage probabilities under the Weibull approach.
For example, with α = 0.5 and σe = 1, we observe
bias of -0.261 (percentage bias of -52.2%) and coverage of
0.4%. In contrast, under the joint modelling approach we
observe minimal bias and coverage probabilities close to
95% across all scenarios.
Analysis of GPRD cohort
We now present the analysis of the GPRD cohort. In all
analyses we use SBP/10 so that a unit increase in SBP/10
represents a clinically meaningful 10 unit increase in SBP.
Our primary interest is the association between baseline
SBP and the risk of stroke. Baseline (tij = 0) corresponds
to when each patient entered the cohort, i.e. the time of
first SBP measurement.
We began by assuming a random intercept and select-
ing the degrees of freedom for the fixed spline terms
using the AIC and BIC. In this case, both selected five
degrees of freedom for sF(tij; kF), with an AIC of 417565.8
and BIC of 417604.1. For the random splines of time we
assumed a linear term, which equates to one spline term
for sR(tij; kR). This allows a very flexible form to take into
account the variation in SBP over time. We further adjust
for age, sex and Body-Mass Index (BMI) at baseline.
For the flexible parametric survival submodel, both AIC
and BIC selected two degrees of freedom, with an AIC
of 2408.7173 and BIC of 2430.483. If one degree of free-
dom had been selected, then this would be equivalent to a
Weibull survival model.
Results are presented in Table 2. Under the standard
flexible parametric survival model we observe a hazard
ratio for a ten unit increase in baseline SBP of 1.111 (95%
CI: 1.051, 1.172). Under a joint model we observe an
increased hazard ratio of 1.198 (95% CI: 1.107, 1.298). The
Table 1 Simulation results of the association parameter, α
True True Weibull Joint model
α σe Bias % bias MSE CP Bias % bias MSE CP
0.1 -0.001 -0.2 0.006 94.8 0.005 0.9 0.006 95.3
0.50 0.5 -0.105 -21.1 0.016 65.4 0.005 0.9 0.007 95.6
1.0 -0.261 -52.1 0.071 0.4 0.008 1.6 0.012 94.8
0.1 0.002 1.0 0.005 94.4 0.005 2.0 0.006 94.3
0.25 0.5 -0.046 -18.5 0.007 89.0 0.007 2.7 0.007 94.5
1.0 -0.123 -49.2 0.018 34.1 0.010 4.1 0.009 94.8
0.1 0.003 -1.3 0.006 93.8 0.001 -0.2 0.006 94.0
-0.25 0.5 0.051 -20.6 0.007 87.1 0.000 -0.1 0.007 94.2
1.0 0.127 -50.7 0.019 29.7 -0.002 0.9 0.009 94.6
0.1 0.000 -0.1 0.006 96.6 -0.005 1.0 0.006 95.9
-0.50 0.5 0.104 -20.9 0.015 66.7 -0.006 1.1 0.007 95.7
1.0 0.260 -52.0 0.070 0.4 -0.010 2.0 0.012 94.5
MSE -mean square error.
CP - coverage probability.
σe - standard deviation of themeasurement error.
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Table 2 Results from applying a flexible parametric proportional hazards model adjusting for observed baseline systolic
blood pressure, and a full joint model using the intercept association structure
Standard FPSM Joint model
Coefficient 95% CI Coefficient 95% CI
Survival model:
Baseline SBP/10 (α2) 0.105 0.050 0.159 0.181 0.102 0.261
Age (years) 0.048 0.036 0.060 0.050 0.038 0.062
Sex (male) 0.011 -0.233 0.254 -0.010 -0.253 0.234
BMI (kg/m2) 0.011 -0.015 0.037 0.013 -0.012 0.039
Longitudinal model:
Intercept - - - 13.006 12.629 13.382
Age (years) - - - 0.025 0.022 0.029
Sex (male) - - - -0.252 -0.332 -0.171
BMI (kg/m2) - - - 0.003 -0.005 0.011
RCS1 - - - -0.080 -0.121 -0.039
RCS2 - - - -0.006 -0.019 0.006
RCS3 - - - -0.001 -0.010 0.007
RCS4 - - - 0.003 0.000 0.006
RCS5 - - - 0.000 -0.001 0.001
σe - - - 1.522 1.515 1.528
FPSM - Flexible Parametric Survival Model.
RCS - Restricted Cubic Spline.
increased effect using a joint model is consistent with that
observed in the simulation study, i.e. that the bias in the
standard survival model is towards the null. The fitted
trajectories seen in Figure 2 appear to capture the subject-
specific measurements well, although some panels appear
to only require a linear trend.
We illustrate how the bias from the standard approach
increases with SBP in Figure 3, showing predictions from
both models for a female patient aged 60, with low (90),
medium (130) and high (200) SBP baselinemeasurements.
To quantify the differences, at 10 years under the stan-
dard model we observe a survival probability of 0.881
for a SBP of 200, compared to 0.816 under the full joint
model.
Discussion
A wealth of patient data is becoming available in registry
sources such as the GPRD, providing extensive oppor-
tunities to utilise the joint modelling framework. We
have shown that by incorporating repeated measures of
a biomarker within a unified joint model framework,
we reduce bias due to measurement error, even when
only the baseline level of the biomarker is predictive of
survival. As illustrated in the simulation study, ignoring
measurement error in biomarkers such as blood pres-
sure can lead to a marked underestimation of covariate
effects. In our application, through the use of restricted
cubic splines in the linear mixed effects submodel, we can
model highly nonlinear trajectories over time, compared
to linear slope models. Furthermore, the flexible paramet-
ric survival submodel can also capture complex baseline
hazard functions, an important component when predict-
ing survival at the patient level [22].
Given that, to our knowledge, all current cardiovas-
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Figure 3 Predicted survival from the flexible parametric survival
model and joint model, for a female, aged 60 years, BMI of 30,
with SBP of 90, 130 or 200.
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adjustment for measurement error, the prospects of util-
ising this framework to improve prognostic risk scores
is quite substantial. Predicting survival for a new patient
using this framework follows naturally, as often only a first
baseline biomarker observation will be available. How-
ever, such amodelling approach also allows a dynamic risk
prediction approach to be adopted, whereby a patient’s
estimated future risk is updated as each new biomarker
value is obtained [23]. Such an approach could enable
response to treatment to be monitored and patients coun-
selled accordingly.
In the analysis of the GPRD cohort, we incorporated
flexibility in both the longitudinal submodel through the
use of restricted cubic splines, and the flexible paramet-
ric survival submodel. Given that both submodels require
choosing the number of degrees of freedom, a simple sen-
sitivity analysis can be undertaken to assess knot locations
and number of knots. We showed recently that the flex-
ible parametric survival submodel is very robust to both
knot placement and number of knots within a joint model
framework [22], and furthermore, an extensive simula-
tion study has been conducted by Rutherford et al. (2013),
which showed excellent performance of the flexible para-
metric model to capture simple and complex baseline
hazard functions [21]. Furthermore, given that primary
interest was in the survival component, and the estimate
of association, often modelling the longitudinal compo-
nent with a suitable sensible functional form will provide
an improved estimate compared to simplistic approaches
of seperate modelling.
In this paper we have concentrated on a specific asso-
ciation structure linking the 2 component submodels;
however, it may be of interest to investigate linking multi-
ple components of a biomarkers trajectory to the time to
an event of interest. For example, recent work by Rothwell
et al. (2010) [24] has shown associations between not only
baseline blood pressure, but also variability over time as
important predictors of cardiovascular events. Further-
more, we have only compared the standard approach of
adjusting for observed baseline biomarker values to the
full joint model. It would be of interest to compare alter-
native approaches for adjusting for measurement error,
not only in baseline biomarkers, but also under a time-
dependent association structure [25,26].
Extensions to the modelling framework include incor-
porating multiple biomarkers. In particular, in our
example we modelled SBP over time, whilst adjusting for
baseline BMI. It may be of interest to model not only
SBP but also the inter-relationships between different
biomarkers such as BMI, and how they are related to an
event of interest [13].
To facilitate the use of the methods in practice, user
friendly Stata software, written by the first author, is
available, with a variety of survival model choices and
association structures, including those discussed in this
article [9,27]. To illustrate computational aspects of the
framework, the presented joint model applied to the
cohort took just over 13 minutes to converge on a stan-
dard laptop computer.
Conclusion
The joint modelling of longitudinal and survival data is a
valid approach to account for measurement error in the
analysis of a repeatedly measured biomarker and a time to
event. User friendly Stata software is provided.
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